Nortrel 7/7/7 Oral Contraceptive Recalled for Discolored Tablets
Teva Pharmaceuticals is recalling Nortrel 7/7/7 oral contraceptive tablets due to a manufacturing defect: discolored blue tablets mixed with white inert tablets. This could cause confusion about which tablets to take in the triphasic regimen.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III classification with no reported illnesses or injuries and a theoretical hazard. Per the severity rubric, precautionary recalls with low-risk manufacturing defects are classified as Moderate.
Plain-English summary
Teva Pharmaceuticals USA, Inc. is recalling Nortrel 7/7/7 (norethindrone and ethinyl estradiol) nationwide. The recall affects 19,824 cartons with lot number 100040731 (expiration date 7/31/2024).
The reason for the recall is a manufacturing defect: blue discolored tablets were found mixed in with the white inert remainder tablets in the cartons. Nortrel 7/7/7 is packaged as a triphasic oral contraceptive regimen, in which each tablet group contains specific hormone levels for different weeks of use.
No illnesses or injuries have been reported in connection with this defect. This is a precautionary recall issued by the manufacturer.
Consumers who have this product should contact their healthcare provider or pharmacist for guidance. Do not use if the package contains discolored blue tablets mixed with white tablets.
The recalled product
- Product
- NORTREL 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)
- Brand
- NORTREL 7/7/7
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Oral Contraceptive
- Hazard
- Affected units
- 19,824
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 100040731
- Exp 7/31/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Teva Pharmaceuticals USA, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Teva Pharmaceuticals USA, Inc
See all →- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- ModerateClaravis isotretinoin 10 mg capsules recalled for out-of-specification impurity
FDA (Drugs) · 2026-04-29
- ModerateTeva clonidine 0.3 mg patches recalled over unapproved raw material use
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Same hazard · discoloration
See all →- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateFresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29